Blueprint Medicines Corp.
(NASDAQ : BPMC)

( )
BPMC PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc. -0.61%77.731.0%$1898.73m
AMGNAmgen, Inc. 3.00%211.581.3%$929.21m
REGNRegeneron Pharmaceuticals, Inc. 2.22%504.272.6%$852.10m
BIIBBiogen, Inc. 3.62%311.391.5%$796.11m
VRTXVertex Pharmaceuticals, Inc. 7.13%255.301.9%$652.54m
MRNAModerna, Inc. -0.57%34.640.0%$571.40m
ILMNIllumina, Inc. 5.51%278.013.5%$493.14m
ALXNAlexion Pharmaceuticals, Inc. 6.84%95.912.0%$303.02m
AAgilent Technologies, Inc. 5.47%74.281.6%$229.86m
INCYIncyte Corp. 8.30%85.112.5%$212.70m
EXASEXACT Sciences Corp. 11.70%62.2721.0%$179.74m
SGENSeattle Genetics, Inc. 6.83%124.476.1%$170.36m
BMRNBioMarin Pharmaceutical, Inc. -1.71%82.774.3%$160.44m
NVAXNovavax, Inc. 3.14%16.10114.7%$125.40m
IMMUImmunomedics, Inc. 99.79%18.7811.9%$114.76m

Company Profile

Blueprint Medicines Corp. is a precision therapy company. It focuses on medicines to improve the lives of patients with genomically defined cancers, rare diseases and cancer immunotherapy. The company was founded by Chris Varma, Nicholas B. Lydon, Brian Druker, and Alexis Borisy on October 14, 2008 and is headquartered in Cambridge, MA.